Although it is exciting to have this new vaccine available to prevent Meningococcal group b disease, the ACIP recommendations are not expected until after their February meeting. Of course, the vast majority of HCPs prudently wait on these recommendations before implementing use of any new vaccine in their practice. Interesting considerations are addressed in Dr. Offit’s mini presentation. Although registering for Medscape is necessary to access it, it’s well worth your time to do so, not only for this information but for the entirety of Medscape’s offerings as well.
http://www.medscape.com/viewarticle/835032